ODT Past Earnings image   This ODT past earnings page last updated 11/11/2021
ODT Past Earnings
Data adjusted for ODT split history

PeriodPast Earnings DateGAAP
Q3 202111/10/2021-0.370
Q2 20217/27/2021-0.580
Q1 20215/14/2021-0.900
Q4 20202/23/2021-0.870
Q3 202010/28/2020-0.930
Q2 20207/30/2020-1.090
Q1 20204/28/2020-0.990
Q4 20192/20/2020-0.910
Q3 201911/7/2019-0.880
Q2 20197/24/2019-1.150
Q1 20194/25/2019-1.160
Q4 20182/22/2019-1.17
Q3 201810/23/2018-0.98
Q2 20187/30/2018-0.79
ODT Past Revenue
PeriodPast Earnings DateGAAP
Q3 202111/10/2021NA
Q2 20217/27/2021NA
Q1 20215/14/2021NA
Q4 20202/23/2021NA
Q3 202010/28/2020NA
Q2 20207/30/2020NA
Q1 20204/28/2020NA
Q4 20192/20/2020NA
Q3 201911/7/2019NA
Q2 20197/24/2019NA
Q1 20194/25/2019NA
Q4 20182/22/2019NA
Q3 201810/23/2018NA
Q2 20187/30/2018NA
Quotes delayed 20 minutes

Email EnvelopeFree ODT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Odonate Therapeutics (ODT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

OFIX Historical Earnings
OGN Historical Earnings
OLMA Historical Earnings
OM Historical Earnings
OMER Historical Earnings
OMGA Historical Earnings
OMI Historical Earnings
OMIC Historical Earnings
ONCR Historical Earnings
ONCS Historical Earnings

ODT Past Earnings Q&A

What was the best and worst ODT past earnings results?
For Odonate Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ODT past earnings result in our data set was -0.370/share posted in Q3 2021, while the lowest was in Q4 2018 when ODT posted -1.17/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2021 when ODT reported NA in revenue, while the quarter with the lowest revenue in our data set was Q3 2021 at NA of revenue.

  Suggested answer: There are 14 ODT past earnings results in our data set.

On this page we presented the ODT past earnings date information for Odonate Therapeutics. Reviewing that ODT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2021, when ODT posted gaap of -0.370/share. Meanwhile the lowest ODT past earnings result was in Q4 2018, when ODT posted gaap of -1.17/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2021 when ODT reported NA in revenue, while the smallest revenue quarter was Q3 2021 when ODT reported NA in revenue.

Any self directed investor doing their due diligence on ODT or any other given stock can benefit from researching all of the Odonate Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Odonate Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ODT. Thanks for visiting, and the next time you need to research ODT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

ODT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.